LIST OF COMMISSION PARTICIPANTS AND INVITEES E. Pete Adams Executive Director Louisiana District Attorneys’ Association Jamie Bolden Louisiana State University Health Sciences Center at New Orleans Luis Alvarado, M.D. President Louisiana Medical Society LaMiesa Bonton Executive Director Addictive Disorders Regulatory Authority M. Lynn Ansardi, R.N. Executive Director Louisiana Board of Practical Nurse Examiners Cheryll Bowers-Stephens, M.D., M.B.A. Medical Director Louisiana Association of Health Plans Bob Barsley, D.D.S., J.D. President Louisiana Dental Association Mitch Bratton President Louisiana Association of Chiefs of Police Lisa Bayhi, DNP President Louisiana Association of Nurse Practitioners Malcolm Broussard Executive Director Louisiana Board of Pharmacy Opioid Commission Chairperson Fabian Blanche, Jr. Louisiana Association of Chiefs of Police Russell Caffery Louisiana Independent Pharmacy Association Cindy Bishop Executive Director Louisiana Orthopedic Association William “Beau” Clark, M.D. Vice President Louisiana Coroner’s Association Ward Blackwell Executive Director Louisiana Dental Association Brandi Cannon Health and Welfare Committee Sharon Brigner Pharmaceutical Research and Manufacturers of America Ed Carlson CLASSP Kathy Chittom Chiropractic Association of Louisiana Shelly Esnard, PA-C Louisiana Academy of Physician Assistants Chuck Cox Louisiana State University Health Sciences Center at Shreveport Rita Finn, R.N. Louisiana State Nursing Association
Daniels, M.D. Louisiana Medical Association Leslie Brougham Freeman, Ph.D. LDH Office of Behavioral Health Roland Dartez Board President Louisiana Association of Self-Insured Employers G.E. D.D.S, M.D. Chancellor and Dean Louisiana State University Health Sciences Center at Shreveport Gerrelda Davis Executive Director Louisiana Primary Care Association Rebecca Gee, M.D. Secretary of the Louisiana Department of Health Ava Dejoie Executive Director The Louisiana Workforce Commission Michael Gomila, Ph.D. LDH Office of Behavioral Health John DeRosier Louisiana District Attorneys’ Association Corinne Green Office of the Governor Jim Donelon Louisiana Commissioner of Insurance Robin Gruenfeld, OPH LDH Perinatal Commission Rochelle Head-Dunham, M.D. Executive Director Metropolitan Human Service District Keetsie Gunnels Assistant Attorney General Louisiana Department of Justice Colonel Mike Edmonson Deputy Secretary of the Louisiana Department of Public Safety Allison Hagan Medicine Louisiana Ross Haman Louisiana District Attorneys’ Association Michael Joseph Hebert President Louisiana Academy of Physician Assistants Ragan LeBlanc Executive Vice President Louisiana Academy of Family Physicians H. Hollier, M.D. Chancellor Louisiana State University Health Sciences Center at New Orleans Kerry Lentini Louisiana Supreme Paul Hubble, M.D. President and Executive Director Society of Interventional Pain Physicians of Louisiana Lars Levy Executive Director Louisiana Association of Drug Court Professionals Ginger Hunt, N.P. President Louisiana Primary Care Association Jeff Linzay, LDH Office of Behavioral Health
cooperation, data sharing, and collaboration with states, the federal government, and local partners, including nonprofit agencies, hospitals, healthcare and medical services providers, and academia to reduce opioid abuse. (5) Evaluation and recommendation of policies and procedures for improved access and more effective opioid abuse treatment and prenatal care for pregnant women with substance abuse problems, including but not limited to clarifying current services available for these women, increasing the number of providers properly trained to provide care to this group, and effective ways to achieve treatment over incarceration. (6) Evaluation of medical professional training and the efficacy of educational materials and public education as an outreach strategy to raise public awareness about the dangers of misuse and abuse of opioid drugs. (7) Assessment of alternatives to incarceration and medical treatment of opioid-addicted individuals suffering from severe substance abuse disorders. (8) Recommendations for any appropriate changes to relevant legislation, administrative rules, or pharmaceutical prescribing to mitigate opioid abuse. The following Commission Report to the legislature encapsulates the committee’s work and the suggestions for each of the topics above. Topic 8, recommendations regarding “appropriate changes to relevant legislation, administrative rules, or pharmaceutical use to mitigate opioid abuse” works to summarize each of the topical areas to provide the Legislature with actionable suggestions. This committee recommends that the Legislature review possible legislation, administrative rules, and policy changes as listed below: Prescriber licensing boards should adopt the CDC guidelines for primary care physicians which focus on the first twelve weeks of therapy.